Stockscreener 앱 받기
31.76
0.63%
-0.24
전일 마감가:
$32.00
열려 있는:
$32.03
하루 거래량:
132.23K
Relative Volume:
0.43
시가총액:
$1.02B
수익:
$566.77M
순이익/손실:
$48.16M
주가수익비율:
26.69
EPS:
1.19
순현금흐름:
$274.29M
1주 성능:
-1.74%
1개월 성능:
+7.03%
6개월 성능:
-4.97%
1년 성능:
-0.48%
1일 변동 폭
$31.69
$32.32
1주일 범위
$31.69
$33.22
52주 변동 폭
$23.23
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
명칭
Collegium Pharmaceutical Inc
전화
781-713-3699
주소
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
COLL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
31.79 | 1.01B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
151.89 | 70.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.71 | 47.44B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.695 | 45.15B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.94 | 19.07B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
298.65 | 13.28B | 2.99B | 1.21B | 1.13B | 25.06 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-05-10 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-10 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-08-25 | 재확인 | Needham | Buy |
| 2023-05-02 | 재개 | Jefferies | Buy |
| 2022-08-08 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-14 | 개시 | BWS Financial | Sell |
| 2020-05-27 | 개시 | Guggenheim | Neutral |
| 2020-02-19 | 재개 | Jefferies | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-05-03 | 재개 | H.C. Wainwright | Buy |
| 2019-04-12 | 재개 | Janney | Buy |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-01-16 | 재확인 | Needham | Buy |
| 2018-03-08 | 재확인 | H.C. Wainwright | Buy |
| 2018-02-07 | 재확인 | Needham | Buy |
| 2017-12-05 | 재확인 | Needham | Buy |
| 2017-09-11 | 개시 | H.C. Wainwright | Buy |
| 2017-05-11 | 재확인 | Needham | Buy |
| 2016-09-13 | 개시 | Gabelli & Co | Buy |
| 2015-06-01 | 개시 | Jefferies | Buy |
| 2015-06-01 | 개시 | Needham | Buy |
| 2015-06-01 | 개시 | Piper Jaffray | Overweight |
모두보기
Collegium Pharmaceutical Inc 주식(COLL)의 최신 뉴스
What makes Collegium Pharmaceutical Inc. stock price move sharplyMassive Gain Ideas - Newser
Why Collegium Pharmaceutical Inc. stock attracts strong analyst attentionMoney Making Low Risk Plans - Newser
How Collegium Pharmaceutical Inc. stock performs during market volatilityTargeted 200 Percent Gain - Newser
(COLL) Technical Pivots with Risk Controls - news.stocktradersdaily.com
8,180 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Purchased by Allspring Global Investments Holdings LLC - Defense World
Collegium Pharmaceutical (COLL) Soars 1.98% on Strong Q1 Earnings - AInvest
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 19% Impressive? - simplywall.st
Collegium announces $150M share repurchase program - MSN
Share Buyback Plan Authorized by Collegium Pharmaceutical (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical authorizes $150 million share repurchase program By Investing.com - Investing.com Nigeria
Collegium Pharma Launches Up To $150 Mln Buyback Program; Stock Up In Pre-market - Nasdaq
Collegium Pharmaceutical authorizes $150 million share repurchase program - Investing.com
Collegium Announces $150 Million Share Repurchase Program - GlobeNewswire
COLL announces $150M share buyback through 2026 – cash-funded | COLL SEC FilingForm 8-K - Stock Titan
Collegium Expands Shareholder Returns With Fresh $150M Stock Buyback After Returning $222M Since 2021 - Stock Titan
Collegium Pharmaceutical (NASDAQ:COLL) Cut to “Buy” at Wall Street Zen - Defense World
How To Trade (COLL) - news.stocktradersdaily.com
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Position Lowered by Illinois Municipal Retirement Fund - Defense World
Janney Montgomery Scott LLC Purchases New Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
State of Alaska Department of Revenue Decreases Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
SG Americas Securities LLC Has $426,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Farther Finance Advisors LLC Boosts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Assenagon Asset Management S.A. Sells 47,897 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Rhumbline Advisers Grows Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
How the (COLL) price action is used to our Advantage - news.stocktradersdaily.com
California State Teachers Retirement System Sells 856 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Director’s Bold Move: Major Stock Sale at Collegium Pharmaceutical - TipRanks
COLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment Priorities - Yahoo Finance
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Position Boosted by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers - Yahoo Finance
Bank of America Corp DE Reduces Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Two Sigma Investments LP Sells 135,582 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
ProShare Advisors LLC Increases Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Millennium Management LLC Raises Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Ameriprise Financial Inc. - Defense World
Deutsche Bank AG Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Jane Street Group LLC Sells 20,543 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) PT at $43.80 - Defense World
Collegium Pharmaceutical's (NASDAQ:COLL) Conservative Accounting Might Explain Soft Earnings - Yahoo Finance
Collegium Pharmaceutical Approves 2025 Equity Incentive Plan - TipRanks
Collegium Pharmaceutical, Inc. to Present at Mizuho Neuro & Ophthalmology Summit and Jefferies Global Healthcare Conference - Nasdaq
Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire
Collegium Pharmaceutical to Present at Mizuho Neuro Summit and Jefferies Healthcare Conference - Stock Titan
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Comerica Bank - Defense World
There May Be Reason For Hope In Collegium Pharmaceutical's (NASDAQ:COLL) Disappointing Earnings - simplywall.st
Voya Investment Management LLC Sells 789 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (COLL) Initiates $25 Million Share Repu - GuruFocus
Collegium Pharmaceutical buys back $25 million in shares By Investing.com - Investing.com Canada
Collegium Pharmaceutical initiates $25M share buyback By Investing.com - Investing.com Canada
Collegium Pharmaceutical Signs $25 Million Accelerated Share Buyback Deal With Jefferies - marketscreener.com
Collegium Announces $25 Million Accelerated Share Repurchase Program - marketscreener.com
Collegium Pharmaceutical Inc (COLL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
9.73%
1.51%
자본화:
|
볼륨(24시간):